Christine Murray - 29 Dec 2022 Form 4 Insider Report for Eiger BioPharmaceuticals, Inc.

Role
Director
Signature
/s/ Sriram Ryali, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
29 Dec 2022
Net transactions value
-$6,104
Form type
4
Filing time
03 Jan 2023, 19:30:25 UTC
Previous filing
11 Mar 2022
Next filing
03 Mar 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EIGR Common Stock Sale $6,104 -5,000 -31% $1.22 11,000 29 Dec 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.